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In this presentation I shall discuss 1) some 
historical highlights in the field of immunology; 2) 
the molecules of immunity, pa_rticularly the im-
munoglo bulins; and 3) the cells of immunity, par-
ticularly the immunocytes. This presentation may 
provide a background for subsequent articles. 
· Some Historical Highlights (Tables 1 and 2). 
From its origins, immunology has been closely asso-
ciated with infectious diseases, a bias from which we 
are only now escaping. In the work of early investi-
gators, we can see the clear demonstrations that 
1) immunity is important in prevention of disease; 
2) there are humoral and cellular phases of the 
immune response; and 3) immune reactions can 
themselves produce disease. 
Edward Jenner (1749-1823) and Vaccination. 
Systematic studies by this quiet scholarly country 
physician established that inoculation with cowpox 
pustules produced immunity to smallpox. The prac-
tice of inoculation or variolation had existed in the 
Orient from early times. Material from the vesicle 
or pustule of an active case of smallpox was inocu-
lated into the. skin in order to produce a mild and '· 
immunizing attack of smallpox. The value of this ' 
method was clearly documented in Benjamin Frank-
lin's pamphlet of 1759, "Some account of the 
success of inoculation for the smallpox in England 
and America." Jenner proved that the much more 
innocent inoculation with cowpox pustules was also 
successful. During his studies he also discovered 
that viruses can be attenuated and that an accele-
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rated response occurs in previously immunized 
persons. His was the first account of an allergic 
reaction in the skin. 
Louis Pasteur (1822-1895) and the First Heroic 
Phase of Immunology. In his thinking, Louis Pas-
teur was against the temper of his times. Anti-
vitalism was dominant. Liebig and other prominent 
scientists had no use for the animalcules postulated 
to explain the origin of disease and fermentation. 
They were wrong, however, and the germ theory 
rose again with Pasteur's studies of the souring of 
milk. His work followed a natural path from studies 
of crystals to studies of diseases of wirte and silk-
worms, to studies of diseases of man, culminating 
in immunization and prevention of disease. The 
studies of chicken cholera revealed that the microbe 
that kills is the one that immunizes and that the 
microbe may be attenuated. They suggested to him 
the possibility of attacking diseases of man. Finally, 
the renowned studies of rabies led to inoculation 
of young Joseph Meister on July 6, 1885 with the 
first and least virulent of his rabies vaccines. Joseph 
survived the series of injections and became the 
gatekeeper at the Pasteur Institute. 
Pasteur's experiments on immunization were 
followed by a great outpouring of studies of immu-
nology with concurrent deveiopment of biologic and 
chemical concepts of immunity. On the biological 
side, Eli Metchnikoff, the wild Russian, migrated 
to Pasteur's laboratory and championed the non-
specific and the cellular aspects of immunity. While 
looking through his microscope, Metchnikoff saw 
cells engulfing particles and became the primary 
discoverer of phagocytosis as a defense mechanism. 
Koch, also at the Pasteur Institute, showed that 
whereas the first intradermal injection of tubercle 
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TABLE 1 
JMMUNOBIOLOGY 
May 14, 1796 Edward Jenner established vaccination. 
July 6, 1885 Louis Pasteur injected attenuated rabies 
virus into Joseph Meister. 
1882 Eli Metchnikoff and phagocytosis. 
To 1905 Bordet,Arthus, vonPirquet, Schick, Ehrlich. 
1953 Owen, Medawar and Burnet. Immunologic 
tolerance. 
bacilli evoked no response in guinea pigs, the sec-
ond injection led to an inflammatory reaction, thus 
initiating the concept of delayed hypersensitivity 
or cellular immunity. 
The Pasteur Institute was also involved in chem-
ical studies of immunity. After Pasteur's work on 
bacteria as the cause of diseases of wine, beer, and 
later, of man, attention turned to diphtheria. Roux 
expected that this devastating disease would be 
characterized by massive bacterial proliferation; but 
only a few bacilli could be isolated from the iocal 
lesion. Something else must be responsible for the 
toxicity of diphtheria. This line of investigation led 
to the isolation of bacterial toxins, the preparation 
of antitoxins, identification of the antitoxins as serum 
TABLE 2 
IMMUNOCHEMISTRY 
October 30, 1845 William Macintyre examined the urine 
of his patient, Mr. Macbee, who had 
myelomatosis. 
1890 
1900 
1920 
1948 
1%0's 
Roux and Behring identified toxiris and 
antitoxins. 
Landsteiner described blood group an-
tigens and antibodies. 
Beginnings of quantitative immuno-
chemistry with Heidelberger, and later, 
Kabat and Marrack. 
Hargraves described the LE cell. 
Fundamental discoveries of antibody 
structure: Putnam, Porter, Edelman, 
Hood, Dreyer. 
proteins, prophylactic use of antitoxin-containing 
sera, and description of serum sickness. This phase 
of research extended through 1905 with the publi-
cation of Serum Sickness by von Pirquet and Schick. 
Forgetting many other important contributions, we 
may tum to 1953 and the development by Owen, 
Medawar, and Burnet of the concept of immuno-
logic tolerance, another landmark in the biology of 
immunity. 
The Chemistry of Immunity. On October 30, 
1845 a practicing physician, William Macintyre, 
examined the urine of his patient, Mr. Macbee, 
who had the disease now known as multiple mye-
loma. The peculiar reactivity of . his urine-a pre-
cipitate formed on warming and dissolved with boil-
ing--led Dr. Macintyre to consult with Dr. Henry 
Bence Jones. More than a hundred years later, 
studies of the Bence Jones proteins ushered in a 
second heroic phase of immunology. Bence Jones 
proteins and serum monoclonal proteins have proved 
to be a Rosetta stone of immunology. 
In 1900 Karl Landsteiner discovered blood 
group antigens and their corresponding antibodies. 
His chemical studies, particularly with low molecular 
weight haptens, set the stage for quantitative im-
munochemistry, developed by Heidelberger and 
Kabat, and by Marrack, from the 1920's through 
the 1950's. The discovery of the LE cell by Har-
graves in 1948 was important because it led to 
detailed studies of the chemical basis of apparent 
autoimmune reactions. Early in the 1960's the work 
of Edelman, Porter, Putnam, and others gave the 
central focus of immunology on the now familiar 
four-chain structure of an antibody monomer. 
The Immunoglobulins. It is fortunate that the 
simple technique of paper or cellulose acetate elec-
trophoresis provides a rather complete separation 
TABLE 3 
THE IMMUNOGLOBULINS 
lgG-The main antibody class. 
lgA-Antibody, especially in secre!ions. 
IgM-Macroglobulins. 
JgD-? 
lgE-Skin sensitizing antibody. 
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of the antibodies. Most antibodies are in the y-
globulin fraction and most y-globulins are antibodies. 
More sophisticated techniques, particularly immuno-
electrophoresis, reveal that some antibodies are in 
other electrophoretic fractions and that there are 
at least five classes of antibodies. These are the 
immunoglobulins: IgG, lgA, IgM, lgD, and lgE 
(Table 3). IgG is the main circulating immuno-
globulin; IgA is prominent in secretions (tears, 
saliva); lgM is generally a pentameric molecule, 
restricted to the intravascular space and particu-
larly effective biologically; IgD is a minor com-
ponent of uncertain function; and lgE is present in 
trace amounts but is extremely important because 
it mediates immediate ( anaphylactic) hypersensi-
tivity. 
A diagrammatic representation (Fig. 1) of the 
IgG molecule reveals that it has four chains-two 
light chains and two heavy chains. The light chains 
(Bence Jones proteins) are often produced in ex-
cess by plasma cells. Large amounts of these proteins 
are excreted by many patients with myelomatosis. 
Variations in amino acid sequences in the first part 
of the light and heavy chains provide variations in 
antibody specificity, that is, antibody diversity. Fur-
ther structural studies reveal that the light chains 
have two and the heavy chains have four disulfide 
domains, homologous parts of the molecule which 
rotate almost independently. Another way to ex-
amine the molecule is literally by looking at it. 
High-resolution electron micrographs reveal the 
lgG molecules to be Y-shaped with the two antigen 
binding sites on the forks. lgM molecules have five 
monomer Y's around a central core. 
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Fig. I-Diagrammatic representation of an lgG molecule. 
Fig. 2-Electron micrograph of a plasma cell from a human 
kidney graft removed because of impending rejection. Note 
the prominent endoplasmic reticulum. (Courtesy of Dr. 
W. J. S. Still, Medical College of Virginia). 
These immunoglobulins are the mediators of 
humoral immunity and are produced by cells of 
the plasma cell series. These secretory cells (Fig. 2) 
have an elaborate endoplasmic reticulum which 
contains the organelles concerned with synthesis 
and secretion of plasma proteins. 
Cellular Immunity. A different group of cells, 
activated lymphocytes, mediate cellular immune re-
actions. Such an activated lymphocyte is see·n in 
figure 3. Upon antigenic stimulation, lymphocytes 
mediating cellular immune reactions enlarge, divide, 
and provide mediators, lymphokines, which incite 
local inflammatory reactions. Cellular immunity is 
largely responsible for immunity against intracellular 
parasites, contact drug allergy, graft rejection, and 
tumor rejection. A typical reaction of cellular im-
munity is the reaction of delayed hypersensitivity, 
such as the tuberculin reaction. 
Observations on patients with immunodeficiency 
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Fig. 3-Electron micrograph of a transformed lymphocyte 
in the splenic white pulp of a lethally x-irradiated mouse 
36 hours after injection of rat small lymphocytes. Note the 
absence of endoplasmic reticulum. This rat lymphocyte 
became transformed after contact with immunologically 
foreign mouse tissue. It is now prepared to provide a line 
of cells mediating the graft-versus-host response. (Courtesy 
of Dr. J. L. Gowans, Oxford University, and publishers, 
S. Karger, Basel/New York).1 
diseases and experiments in animals have given 
rise to the concept of two different systems that 
mediate humoral and cellular immunity (Fig. 4). 
According to this view, stem cells from the bone 
marrow migrate to breeding sites for the cells of 
the two types of immunity. In the chicken, plasma 
1 Reprinted by permission from Gowans JL, McGregor 
DD : The immunological activities of lymphocytes. Progress 
in Allergy 9: 1, 1965. 
cell precursors (B cells) are produced in the bursa 
of Fabricius, an organ near the cloaca. In man, the 
- corresponding tissues are not clearly identified. The 
marrow itself or gut-associated lymphoid tissue may 
be involved. The second breeder site is the thymus. 
It provides T lymphocytes and cellular immunity. 
Interrelations of T and B cells are complicated and 
important, as some of the following presentations 
will indicate. 
In this brief overview, I have presented some 
historical highlights of chemical and biologic ap-
proaches to immunology. The chemical approaches 
lead to our current detailed picture of immuno-
globulin structure. The biologic studies lead to the 
concept of a two-component system, B and T cells, 
mediating humoral and cellular immunity. These 
chemical and biologic findings provide a framework 
for analyzing not only basic immunology but also 
clinical diseases. For completion, I should briefly 
mention the scavenger macrophages-probably im-
portant in antigen processing; the complement sys-
tem-important in amplifying the effects of an 
immune response; the kinins and other molecules 
of inflammation; and the polymorphonuclear leuko-
cytes and other apparently nonspecific defenders. 
The Immunologic Mosaic. The outlines of mod-
ern immunology are now discernible. The resultant 
picture is like a mosaic rather than a photograph. We 
are now at the exciting point where the form is 
emerging. 
BONE MARROW 
! 
Stem4 Cells 
~ ~URSA-LIK~ TISSUES! 
Thymic (T) tymphocytes i Bursa! (B) Lymphocytes 
Lymph nodes, spleen, Peyer's patches 
J, + Antig.en (Ag) 
Ag-specific transformed lymphocytes 
"'lJ .!~ 
Proliferation of thymic- dependent and 
antigen-sper '.fic lymphocytes in para-
cortica l areas -+Ag- specific cellular 
immunity (delayed hype rsensitivity) 
(cell-bound antibody) and immunologic 
memory . 
Proliferation of bursal-dependent 
and antigen specific lymphocytes 
in germinal centers and develop-
ment of plasma cells - Ag-specific 
humeral immunity (circulating antibodies) 
(lg's) and im munologic memory . 
Fig. 4-Bone marrow - thymus - bursa interrelations. The 
bursa-like tissues in man may be either the bone marrow 
itself or certain gut-associated lymphoid tissues (GALT). 
